Evidence map›Paper›PMID 36323319›Full record

ArticleACS synthetic biology2022

Unusual Class I Lanthipeptides from the Marine Bacteria

Ross Vermeulen, Anton Du Preez Van Staden, Leonardo Joaquim van Zyl, Leon M T Dicks, Marla Trindade

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS synthetic biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Structure, biosynthesis, and bioactivity of nostolysamides.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Bacterial natural product discovery by heterologous expression.Journal of industrial microbiology & biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ross VermeulenDepartment of Microbiology, Stellenbosch University, Matieland 7602, South Africa.ORCID 0000-0002-2223-4364
Anton Du Preez Van StadenDepartment of Microbiology, Stellenbosch University, Matieland 7602, South Africa.ORCID 0000-0003-0596-8849
Leonardo Joaquim van ZylDepartment of Biotechnology, Institute for Microbial Biotechnology and Metagenomics (IMBM), University of the Western Cape, Bellville 7535 South Africa.
Leon M T DicksDepartment of Microbiology, Stellenbosch University, Matieland 7602, South Africa.ORCID 0000-0002-5157-9046
Marla TrindadeDepartment of Biotechnology, Institute for Microbial Biotechnology and Metagenomics (IMBM), University of the Western Cape, Bellville 7535 South Africa.ORCID 0000-0002-2478-0270

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel class I lanthipeptide produced by the marine bacterium

Indexed as

BacteriocinsEscherichia coliGammaproteobacteriaPeptidesProtein Processing, Post-TranslationalBacteriocinsPeptidesclass I lanthipeptidesEscherichia coli heterologous expressionGFP fusionGram-negativenatural product discoveryviridisin

Identifiers

PMID36323319
PMCPMC9680876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.